Filtered By:
Cancer: Skin Cancer

This page shows you your search results in order of relevance. This is page number 11.

Order by Relevance | Date

Total 39067 results found since Jan 2013.

Vascular Endothelial Growth Factor A (VEGF-A) and Vascular Endothelial Growth Factor Receptor 2 (VEGFR-2) as Potential Biomarkers for Oral Squamous Cell Carcinoma: A Sri Lankan Study
CONCLUSIONS: VEGF-A gene expression, serum levels, and tissue VEGFR-2 levels correlated linearly with the stage and grade of the tumor. This study justifies the value of VEGF-A as a potential biomarker in OSCC in early detection of OSCC. More studies are needed to accept the use of VEGF-A.PMID:36708576 | DOI:10.31557/APJCP.2023.24.1.267
Source: Asian Pacific Journal of Cancer Prevention - January 28, 2023 Category: Cancer & Oncology Authors: Sajith Tilal Edirisinghe Manjula Weerasekera Dulmini Kavindya De Silva Movini Thisara Devmini Shanaka Pathmaperuma Gayan Kanchana Wijesinghe Thilini Nisansala Anuradha Maddumage Haizal Huzaini Alison M Rich Harsha De Silva Milne Trudy Renuka Goonasinghe K Source Type: research

Cancers, Vol. 15, Pages 1436: Chick Chorioallantoic Membrane as a Patient-Derived Xenograft Model for Uveal Melanoma: Imaging Modalities for Growth and Vascular Evaluation
Conclusion: The establishment of a CAM-PDX uveal melanoma model could elucidate the biological growth patterns and the efficacy of new therapeutic options in vivo. The methodological novelty of this study, investigating different implanting techniques and exploiting advances in real-time imaging with multiple modalities, allows precise, quantitative assessment in the field of tumor experimentation, underlying the feasibility of CAM as an in vivo PDX model.
Source: Cancers - February 24, 2023 Category: Cancer & Oncology Authors: Theodora Tsimpaki Nikolaos E. Bechrakis Berthold Seitz Miriam M. Kraemer Hongtao Liu Sami Dalbah Ekaterina Sokolenko Utta Berchner-Pfannschmidt Miltiadis Fiorentzis Tags: Article Source Type: research

Vascular Endothelial Growth Factor A (VEGF-A) and Vascular Endothelial Growth Factor Receptor 2 (VEGFR-2) as Potential Biomarkers for Oral Squamous Cell Carcinoma: A Sri Lankan Study
CONCLUSIONS: VEGF-A gene expression, serum levels, and tissue VEGFR-2 levels correlated linearly with the stage and grade of the tumor. This study justifies the value of VEGF-A as a potential biomarker in OSCC in early detection of OSCC. More studies are needed to accept the use of VEGF-A.PMID:36708576 | DOI:10.31557/APJCP.2023.24.1.267
Source: Asian Pacific Journal of Cancer Prevention - January 28, 2023 Category: Cancer & Oncology Authors: Sajith Tilal Edirisinghe Manjula Weerasekera Dulmini Kavindya De Silva Movini Thisara Devmini Shanaka Pathmaperuma Gayan Kanchana Wijesinghe Thilini Nisansala Anuradha Maddumage Haizal Huzaini Alison M Rich Harsha De Silva Milne Trudy Renuka Goonasinghe K Source Type: research

Antitumor effect of anti-vascular therapy with STING agonist depends on the tumor microenvironment context
ConclusionThe study provides preclinical evidence for a great influence of the TME on the outcome of applied therapy, including immune cell contribution and ICI responsiveness. We pointed the need of careful TME screening prior to antitumor treatments to achieve satisfactory results.
Source: Frontiers in Oncology - August 15, 2023 Category: Cancer & Oncology Source Type: research

Malignant Superior Vena Cava Syndrome: A Comparative Cohort Study of Treatment with Covered Stents versus Uncovered Stents Vascular and Interventional Radiology
Conclusion: Endovascular placement of ePTFE-covered stents appeared to be a safe and effective method to treat patients with malignant SVC syndrome and seemed to be superior to uncovered stents in terms of stent patency. © RSNA, 2012
Source: Radiology - February 20, 2013 Category: Radiology Authors: Gwon, D. I., Ko, G.-Y., Kim, J. H., Shin, J. H., Yoon, H.-K., Sung, K.-B. Tags: Interventional Radiology, Vascular Imaging, Gastrointestinal Radiology Vascular and Interventional Radiology Source Type: research

A novel human anti-syndecan-1 antibody inhibits vascular maturation and tumour growth in melanoma
Conclusion: These findings highlight the role of syndecan-1 as a potential therapeutic target in melanoma and ovarian carcinoma and provide a new tool able to block vessel maturation, one of the mechanisms that underpin the angiogenic process essential for solid tumour growth.
Source: European Journal of Cancer - January 28, 2013 Category: Cancer & Oncology Authors: Paola Orecchia, Romana Conte, Enrica Balza, Andrea Petretto, PierLuigi Mauri, Maria Cristina Mingari, Barbara Carnemolla Tags: Basic and preclinical research Source Type: research